As direct-to-consumer (DTC) genetic testing grows in popularity with the public, more people are bringing their results to their medical providers. Whether it be curiosity, concern, or even panic, patients may have questions about what their results mean for their health. In some cases, DTC genetic testing can provide clinically relevant results, but generally, DTC genetic testing results may not be not sufficient or appropriate for making health risk assessments. Additional testing may be warranted. In this webinar, we will review the technical differences between common DTC testing and clinical diagnostic genetic testing and will explore the circumstances in which each is appropriate. We will review some clinical scenarios and discuss how to advise patients who are interested in DTC testing or who have test results to review.
Selecting a Test for Your Patient (DTC vs. Single Gene vs. Panel vs. Exome) with Stephany Connor, MS & Johanna Schmidt, MPH, MGC, LCGC
Stephany earned her bachelor’s degree from Purdue University in 2000 and worked in academic research labs for five years before attending graduate school at Arcadia University where she earned her degree in genetic counseling. After graduate school, Stephany worked both pediatric and cancer clinics for Southern California Kaiser Permanente. Stephany joined Ambry Genetics in the beginning of 2012 and is currently a supervisor of the genetic counselor cancer reporting team.
Johanna Schmidt, MPH, MGC, LCGC earned her Master’s in Public Health from the University of Michigan (2006) and her Master’s in Genetic Counseling from the University of Maryland (2010). She was a research and clinic coordinator for the Myelin Disorders Bioregistry Project at Children’s National Medical Center in Washington, D.C. for three years before moving to Los Angeles, California. In 2014, she began her private practice and independent consulting company, Westside Genetic Counseling.
Tameron joined Ambry Genetics as an Oncology Genetic Specialist in 2016. She completed her Bachelor of Science from Lipscomb University with a dual major in biology and psychology. After working in the biotech field for several years, Tameron returned to school at Vanderbilt University for her Master of Science in Nursing. She spent the next 15+ years working in the field of oncology where her past work in genotyping led to a strong interest in inherited cancer syndromes. She has completed the City of Hope Intensive Course in Cancer Risk Assessment in order to expand her genetics knowledge enabling her to be a resource for providers who wish to provide genetic education and testing to their patients.
- Fri, March 29, 2019
- 12:00pm PDT
- Duration: 1 hour
-
C.E.U.
1 Category 1 Contact Hour
- P.A.C.E. 1 unit